Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-27
2009-10-13
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S215000, C514S268000, C514S269000, C514S270000, C514S241000, C514S263210, C514S263220
Reexamination Certificate
active
07601723
ABSTRACT:
The present invention provides compounds and pharmaceutical compositions that are substituted pyridyl-linked-xanthines of formula Iwhich are selective antagonists of A2Badenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
REFERENCES:
patent: 5097097 (1992-03-01), Wang et al.
patent: 6916606 (2005-07-01), Massey et al.
patent: 7148229 (2006-12-01), Dunten et al.
patent: 2004/0192708 (2004-09-01), Dunten et al.
patent: 2007/0066631 (2007-03-01), Wang et al.
patent: 2007/0105821 (2007-05-01), Wang et al.
patent: 2007/0249598 (2007-10-01), Wang et al.
patent: WO1077110 (2001-10-01), None
Frandsen et al, Carcinogenesis, Jun. 2000; 21: 1197-1203.
Klosa, J. Prak. Chemie 22, 259-266 (1963).
Rieger Jayson M.
Thompson Robert D.
Wang Guoquan
Berch Mark L
PGx Health, LLC
LandOfFree
Pyridyl substituted xanthines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridyl substituted xanthines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridyl substituted xanthines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073057